Background: Diagnosing bipolar disorder poses a challenge in clinical practice and demands a substantial time investment. With the growing utilization of artificial intelligence in mental health, researchers are endeavoring to create AI-based diagnostic models. In this context, some researchers have sought to develop machine learning models for bipolar disorder diagnosis. Nevertheless, the accuracy of these diagnoses remains a subject of controversy. Consequently, we conducted this systematic review to comprehensively assess the diagnostic value of machine learning in the context of bipolar disorder.
Methods: We searched PubMed, Embase, Cochrane, and Web of Science, with the search ending on April 1, 2023. QUADAS-2 was applied to assess the quality of the literature included. In addition, we employed a bivariate mixed-effects model for the meta-analysis.
Results: 18 studies were included, covering 3152 participants, including 1858 cases of bipolar disorder. 28 machine learning models were encompassed. Sensitivity and specificity in discriminating between bipolar disorder and normal individuals were 0.88 (9.5% CI: 0.74~0.95) and 0.89 (95% CI: 0.73~0.96) respectively, and the SROC curve was 0.94(95% CI: 0.92~0.96). The sensitivity and specificity for distinguishing between bipolar disorder and depression were 0.84 (95%CI: 0.80~0.87) and 0.82 (95%CI: 0.75~0.88) respectively. The SROC curve was 0.89 (95%CI: 0.86~0.91).
Conclusions: Machine learning methods can be employed for discriminating and diagnosing bipolar disorder. However, in current research, they are predominantly utilized for binary classification tasks, limiting their progress in clinical practice. Therefore, in future studies, we anticipate the development of more multi-class classification tasks to enhance the clinical applicability of these methods.
Systematic Review Registration: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42023427290, identifier CRD42023427290.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11810903 | PMC |
http://dx.doi.org/10.3389/fpsyt.2024.1515549 | DOI Listing |
JAMA Psychiatry
March 2025
Institute of Behavioral Science, Feinstein Institutes for Medical Research, Manhasset, New York.
Importance: Peripheral (blood-based) biomarkers for psychiatric illness could benefit diagnosis and treatment, but research to date has typically been low throughput, and traditional case-control studies are subject to potential confounds of treatment and other exposures. Large-scale 2-sample mendelian randomization (MR) can examine the potentially causal impact of circulating proteins on neuropsychiatric phenotypes without these confounds.
Objective: To identify circulating proteins associated with risk for schizophrenia (SCZ), bipolar disorder (BD), and major depressive disorder (MDD) as well as cognitive task performance (CTP).
Aging Dis
March 2025
First Clinical Medical College, Heilongjiang University of Chinese Medicine, Harbin 150040, China.
Recent advances in microbial pathogen research have highlighted the potential of gut microbe-based microbial medicine. One of the most extensively studied biological pathways is the gut-brain axis, which has been shown to reverse neurological disorders. Evidence from animal-based studies of dysbiosis suggest complex behavioral changes, such as alterations in sociability and anxiety, can be modulated through gut microbiota.
View Article and Find Full Text PDFEpilepsia
March 2025
Department of Clinical Biochemistry, Holbæk Hospital, Holbæk, Denmark.
Objective: The aim of the study is to provide insight into the real-world use of therapeutic drug monitoring (TDM) for the most common antiseizure medications (ASMs).
Methods: In total, 137 586 samples from the period 2019-2023 were collected from the five main Danish laboratories performing TDM. A previously described algorithm developed to exclude abnormal TDM results from patient data was applied.
Psychol Med
March 2025
Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
Background: Sustained attention is integral to goal-directed tasks in everyday life. It is a demanding and effortful process prone to failure. Deficits are particularly prevalent in mood disorders.
View Article and Find Full Text PDFCureus
February 2025
Psychiatry, Hatsuishi Hospital, Kashiwa, JPN.
Corticosteroid treatment sometimes causes psychiatric side effects such as mania, depression, and psychosis. It is believed that exogenous corticosteroids lead to dysregulation of corticosteroid signaling and neurotransmitters in a dose-dependent manner. Therefore, the administration of corticosteroids is at risk of worsening bipolar disorder.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!